Literature DB >> 9620797

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.

L M McLatchie1, N J Fraser, M J Main, A Wise, J Brown, N Thompson, R Solari, M G Lee, S M Foord.   

Abstract

Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620797     DOI: 10.1038/30666

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  494 in total

1.  Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).

Authors:  F M Wisskirchen; D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues.

Authors:  P Chakravarty; T P Suthar; H A Coppock; C G Nicholl; S R Bloom; S Legon; D M Smith
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals.

Authors:  A Sams-Nielsen; C Orskov; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

5.  Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens.

Authors:  D R Poyner; G M Taylor; A E Tomlinson; A G Richardson; D M Smith
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP.

Authors:  P J Lupardus; R A Wilke; E Aydar; C P Palmer; Y Chen; A E Ruoho; M B Jackson
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

7.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

8.  BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).

Authors:  Raphaela Verheggen; Katja Bumann; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

9.  CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.

Authors:  P Hasbak; A Sams; S Schifter; J Longmore; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

10.  Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein.

Authors:  Thomas J Thekkumkara; Stuart L Linas
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.